SARS-CoV-2 enzyme Hel
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | <SX viewer='molstar' load='6zsl' size='340' side='right' caption='Crystal structure of the SARS-CoV-2 helicase at 1.94 Angstrom resolution (PDB | + | <SX viewer='molstar' load='6zsl' size='340' side='right' caption='Crystal structure of the SARS-CoV-2 helicase at 1.94 Angstrom resolution (PDB 6zsl).' scene=''> |
'''Non-structural protein 13 (nsp13)/ Helicase (Hel)''' | '''Non-structural protein 13 (nsp13)/ Helicase (Hel)''' | ||
Current revision
|
References
- ↑ 1.0 1.1 Yoshimoto FK. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. Protein J. 2020 Jun;39(3):198-216. doi: 10.1007/s10930-020-09901-4. PMID:32447571 doi:http://dx.doi.org/10.1007/s10930-020-09901-4
- ↑ Konkolova E, Klima M, Nencka R, Boura E. Structural analysis of the putative SARS-CoV-2 primase complex. J Struct Biol. 2020 Aug 1;211(2):107548. doi: 10.1016/j.jsb.2020.107548. Epub, 2020 Jun 11. PMID:32535228 doi:http://dx.doi.org/10.1016/j.jsb.2020.107548
- ↑ 3.0 3.1 3.2 Chen J, Malone B, Llewellyn E, Grasso M, Shelton PMM, Olinares PDB, Maruthi K, Eng ET, Vatandaslar H, Chait BT, Kapoor TM, Darst SA, Campbell EA. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex. Cell. 2020 Jul 28. pii: S0092-8674(20)30941-7. doi: 10.1016/j.cell.2020.07.033. PMID:32783916 doi:http://dx.doi.org/10.1016/j.cell.2020.07.033
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R. A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells. 2020 May 20;9(5). pii: cells9051267. doi: 10.3390/cells9051267. PMID:32443810 doi:http://dx.doi.org/10.3390/cells9051267
- ↑ Krafcikova P, Silhan J, Nencka R, Boura E. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nat Commun. 2020 Jul 24;11(1):3717. doi: 10.1038/s41467-020-17495-9. PMID:32709887 doi:http://dx.doi.org/10.1038/s41467-020-17495-9
- ↑ Yuen CK, Lam JY, Wong WM, Mak LF, Wang X, Chu H, Cai JP, Jin DY, To KK, Chan JF, Yuen KY, Kok KH. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect. 2020 Dec;9(1):1418-1428. doi:, 10.1080/22221751.2020.1780953. PMID:32529952 doi:http://dx.doi.org/10.1080/22221751.2020.1780953